Counseling could have physical and treatment benefits for breast cancer patients

March 2008
Hem/Onc Today;3/10/2008, Vol. 9 Issue 4, p60
This article discusses findings of a study conducted by researchers from the Ohio State University, which indicated that employing psychological interventions for patients with breast cancer could help improve their health and allow for increased tolerance of chemotherapy. In the study, 227 stage II or III patients with breast cancer who had mastectomies and were administered chemotherapy have been examined.


Related Articles

  • Cyclophosphamide/epirubicin/fluorouracil.  // Reactions Weekly;12/1/2007, Issue 1180, p12 

    The article describes the case of a 41-year-old breast cancer patient who developed a manic episode after receiving chemotherapy which included fluorouracil, epirubicin and cyclophosphamide. After receiving her first 3-weekly cycle of fluorouracil, epirubicin and cyclophosphamide, the patient...

  • Paclitaxel + carboplatin an option in advanced breast cancer.  // PharmacoEconomics & Outcomes News;11/6/2004, Issue 465, p6 

    Reports on the study of chemotherapy in patients with advanced breast cancer in Greece. Response rates in the carboplatin and epirubicin groups; Median time to treatment failure; Cost of treatment in the two groups.

  • Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Londero, Viviana; Bazzocchi, Massimo; Del Frate, Chiara; Puglisi, Fabio; Di Loreto, Carla; Francescutti, Giuliana; Zuiani, Chiara // European Radiology;Aug2004, Vol. 14 Issue 8, p1371 

    The accuracy of mammography, sonography and magnetic resonance imaging (MRI) in identifying residual disease after neoadjuvant chemotherapy is evaluated and imaging findings are correlated with pathologic findings. Fifteen patients enrolled in an experimental protocol of preoperative neoadjuvant...

  • Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer. Nolè, Franco; Crivellari, D.; Mattioli, R.; Pinotti, G.; Foa, P.; Verri, E.; Fougeray, R.; Brandely, M.; Goldhirsch, A. // Cancer Chemotherapy & Pharmacology;Sep2009, Vol. 64 Issue 4, p673 

    Combination of intravenous (i.v.) vinorelbine and capecitabine was shown to be feasible and effective in metastatic breast cancer (MBC). In an effort to improve patient convenience and to prolong infusion-free survival, we investigated in first-line treatment a regimen combining oral vinorelbine...

  • More on Breast Cancer in the Elderly. Ershler, William B. // Clinical Oncology Alert;Oct2007, Vol. 23 Issue 10, p78 

    ONCOLOGISTS HAVE BECOME INCREASINGLY aware of geriatric issues relating to cancer management. These issues are particularly relevant to breast cancer because the majority of patients are over the age of 65 years and there are important and well recognized age-associated differences in tumor...

  • Breast Cancer Cured at Home. Gerson, Charlotte // Gerson Healing Newsletter;Jul/Aug2004, Vol. 19 Issue 4, p8 

    Relates the story of breast cancer patient named Joyce in California. Complications of the cancer; Measurement of the tumor; Recommendation for chemotherapy and radiation.

  • VIRTUAL REALITY INTERVENTION FOR CHEMOTHERAPY SYMPTOMS. Schneider, Susan // Oncology Nursing Forum;Mar2006, Vol. 33 Issue 2, p407 

    Successful completion of chemotherapy offers a greater chance for tumor response and quality of life. Many patients have difficulty adhering to the regimen because of chemotherapy-related symptoms. Virtual reality (VR) provides a distracting, immersive environment, which blocks out competing...

  • Neoadjuvant Therapy for Breast Cancer.  // Current Medical Literature: Breast Cancer;2009, Vol. 21 Issue 2, p45 

    The article presents data supporting neoadjuvant endocrine therapy as a safe substitute to chemotherapy among breast cancer patients. It cites the differences between chemotherapy and neoadjuvant endocrine therapy based on randomized controlled tests. It discusses the benefits of neoadjuvant...

  • Evidence for Classically Conditioned Fatigue Responses in Patients Receiving Chemotherapy Treatment for Breast Cancer. Bovbjerg, Dana; Montgomery, Guy; Raptis, George // Journal of Behavioral Medicine;Jun2005, Vol. 28 Issue 3, p231 

    Fatigue is the most common side effect of chemotherapy for cancer. Not yet explored is the possibility that patients may develop conditioned fatigue responses to clinic cues as a result of the repeated pairing of the clinic environment (conditioned stimulus) with infusions of chemotherapy...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics